Cumulus Neuroscience, a global digital health company developing multi-domain digital biomarkers for the brain, was selected by renowned life sciences forum CNS Summit to present at its annual Innovation Showcase, and for a poster presentation illustrating the reliability of real world digital end-points of functional neurophysiology. Chief Executive Officer, Aman Bhatti, MD, will also participate in a main-stage panel discussion about diversity in clinical trials hosted by Medidata and CircuitClinical.
“At the heart of scientific innovation is collaboration and knowledge sharing,” said Dr. Bhatti. “The CNS Summit gathers the life sciences community united around a shared goal — to accelerate innovation and improve patient experience and outcomes. We are honored to not only attend alongside and learn from these leaders but to present our own vital research and discuss the future of research, diagnosis and treatment for neuropsychological conditions.”
Also Read: PathGroup and uMETHOD Health Partner to Personalize Care for Mild Cognitive Impairment
At the 2022 CNS Summit, Cumulus Neuroscience will be present in multiple ways:
- Innovation Showcase: Dr. Bhatti and Cumulus founder and Chief Scientific Officer, Brian Murphy, Ph.D., will present and pitch to pharmaceutical leaders in the morning session on Friday, November 18th
- Poster Presentations: Cumulus Neuroscience will display a poster presentation on Friday, November 18th at booth #18 on the reliability of real world digital end-points of functional neurophysiology
- Panel Participation: Hosted by Medidata and CircuitClinical, Dr. Bhatti will participate in “Live with Kelly and Dana: A 360 View of Diversity in Clinical Trials” on February 18 at 12pmET.
“Diversity in clinical trials is a critical factor in creating a more equitable health landscape, but commitment to this effort must be reflected in every step of the process,” added Dr. Bhatti. “By joining the voices of leaders in the industry, we can advance therapies that help a wide range of patients.”
The CNS Summit takes place from November 17-20 in Boca Raton, Florida, and brings together leading pharma and biotech executives dedicated to innovating care in the life sciences.
Cumulus Neuroscience is a leader in advancing clinical trial data, creating tools for its partners to harness data, and transforming and accelerating diagnosis and care for patients with central nervous system disorders.